Go to main content | Go to main menu | Go to search

Project information
Telomerase activity as a novel prognostic factor in multiple myeloma

Information

This project doesn't include Faculty of Science. It includes Faculty of Medicine. Official project website can be found on muni.cz.
Project Identification
NC7043
Project Period
1/2002 - 12/2004
Investor / Pogramme / Project type
Ministry of Health of the CR
  • R&D of Oncology
MU Faculty or unit
Faculty of Medicine
Keywords
multiple myeloma;prognostic factors;telomerase
Cooperating Organization
Institute of Biophysics
  • Responsible person prof. RNDr. Jiří Fajkus, CSc.
University Hospital Brno-Bohunice
  • Responsible person prof. MUDr. Miroslav Penka, CSc.

Telomerase assay in multiple myeloma is new perspective prognostic factor in multiple myeloma The use od hTERT as tumor antigen is promising new treatment modality and could circumvent limitation of current vaccination protocols in multiple myeloma in which low immunogenic antigens and consequently minimal responses are reported.

Publications

Total number of publications: 4

2005

2004

You are running an old browser version. We recommend updating your browser to its latest version.